Trypanosoma cruzi proline racemases are involved in parasite differentiation and infectivity

Department of Immunology, Institut Pasteur, CNRS, URA1961, Paris 75724, France.
Molecular Microbiology (Impact Factor: 4.42). 11/2005; 58(1):46-60. DOI: 10.1111/j.1365-2958.2005.04808.x
Source: PubMed


Polyclonal lymphocyte activation is one of the major immunological disturbances observed after microbial infections and among the primary strategies used by the parasite Trypanosoma cruzi to avoid specific immune responses and ensure survival. T. cruzi is the insect-transmitted protozoan responsible for Chagas' disease, the third public health problem in Latin America. During infection of its mammalian host, the parasite secretes a proline racemase that contributes to parasite immune evasion by acting as a B-cell mitogen. This enzyme is the first described eukaryotic amino acid racemase and is encoded by two paralogous genes per parasite haploid genome, TcPRACA and TcPRACB that give rise, respectively, to secreted and intracellular protein isoforms. While TcPRACB encodes an intracellular enzyme, analysis of TcPRACA paralogue revealed putative signals allowing the generation of an additional, non-secreted isoform of proline racemase by an alternative trans-splicing mechanism. Here, we demonstrate that overexpression of TcPRAC leads to an increase in parasite differentiation into infective forms and in its subsequent penetration into host cells. Furthermore, a critical impairment of parasite viability was observed in functional knock-down parasites. These results strongly emphasize that TcPRAC is a potential target for drug design as well as for immunomodulation of parasite-induced B-cell polyclonal activation.

Download full-text


Available from: Jean-Christophe Barale
  • Source
    • "Surveys in the 1970s showed that 71% of free-ranging elk in western Wyoming were infected with T. cervi (Kingston et al. 1981). Trypanosoma cruzi and other blood parasites have been implicated in inducing chronic infections by modulating the host immune response via mechanisms such as those mediated by PrpA (Palanivel et al. 1996; Montes et al. 2002; Chamond et al. 2005). We propose that T. cervi acts similar to other trypanosomes in suppressing immune activation. "
    [Show abstract] [Hide abstract]
    ABSTRACT: abstract : Brucellosis, which results in fetal abortions in domestic and wildlife animal populations, is of major concern in the US and throughout much of the world. The disease, caused by Brucella abortus, poses an economic threat to agriculture-based communities. A moderately efficacious live attenuated vaccine (B. abortus strain RB51) exists. However, even with vaccine use, outbreaks occur. Evidence suggests that elk (Cervus canadensis), a wild host reservoir, are the source of recent outbreaks in domestic cattle herds in Wyoming, USA. Brucella abortus establishes a chronic, persistent infection in elk. The molecular mechanisms allowing the establishment of this persistent infective state are currently unknown. A potential mechanism could be that concurrent pathogen burdens contribute to persistence. In Wyoming, elk are chronically infected with Trypanosoma cervi, which may modulate host responses in a similar manner to that documented for other trypanosomes. To identify any synergistic relationship between the two pathogens, we simulated coinfection in the well-established murine brucellosis model using Trypanosoma musculi and B. abortus S19. Groups of C57BL/6 mice (Mus musculus) were infected with either B. abortus strain 19 (S19) or T. musculi or both. Sera were collected weekly; spleens from euthanized mice were tested to determine bacterial load near the end of normal brucellosis infection. Although changes in bacterial load were observed during the later stages of brucellosis in those mice coinfected with T. musculi, the most significant finding was the suppression of gamma interferon early during the infection along with an increase in interleukin-10 secretion compared with mice infected with either pathogen alone. These results suggest that immune modulatory events occur in the mouse during coinfection and that further experiments are warranted to determine if T. cervi impacts Brucella infection in elk.
    Full-text · Article · Oct 2013 · Journal of wildlife diseases
  • Source
    • "The T. cruzi proline racemase gene TcPRACA, an enzyme that interconverts free l-proline and d-proline enantiomers [55], is a very similar example: it can produce mRNAs coding for either secreted or cytoplasmic protein. The secreted form is only expressed in metacyclic and trypomastigote stages [53] [56] and acts as a B-cell mitogen that helps to shift the host immune response towards a non-specific response [55]. The cytoplasmic version may play a role in regulating metabolism in epimastigotes [53] [55]. "
    [Show abstract] [Hide abstract]
    ABSTRACT: Kinetoplastids, including the human pathogens Trypanosoma brucei, Trypanosoma cruzi and Leishmania, are the only known organisms that do not regulate the transcription of protein coding genes transcribed by RNA polymerase II. Yet, profound changes in gene expression are induced by many different external stimuli and stresses, the extreme example are cascades of changes in gene expression initiated by differentiation triggers that ultimately and irreversibly result in the massive morphological and metabolic changes observed during life-cycle progression. This review explores how kinetoplastids change gene expression by looking at life-cycle stage specific changes in chromatin, mRNA processing, mRNA stability, mRNA translation, protein stability and protein modifications.
    Full-text · Article · Feb 2012 · Molecular and Biochemical Parasitology
  • Source
    • "Interestingly, intracellular forms (amastigotes and intracellular epimastigotes) fulfill their energy requirements mainly from metabolites other than glucose, especially proline [176]. As previously mentioned, this amino acid also participates in the differentiation process from T. cruzi epimastigote to trypomastigote in the insect vector [186] [187] [213] and in the differentiation of the intracellular epimastigote to the trypomastigote forms in the mammalian host, a process that occurs in the cytoplasm of infected mammalian host cells [188]. In addition, it is well established that adhesion to the host cell surface prior to invasion requires the parasite to expend energy [214]. "
    [Show abstract] [Hide abstract]
    ABSTRACT: Trypanosoma cruzi is the causative agent of Chagas' disease, which affects some 8 - 10 million people in the Americas. The only two drugs approved for the etiological treatment of the disease in humans were launched more than 40 years ago and have serious drawbacks. In the present work, we revisit the unique characteristics of T. cruzi mitochondria and mitochondrial metabolism. The possibility of taking advantage of these peculiarities to target new drugs against this parasite is also discussed.
    Full-text · Article · Jun 2011 · Current pharmaceutical design
Show more